Black Rock Inc. Palisade Bio, Inc. Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.41 - $1.04 $8,589 - $21,786	-20,949 Reduced 97.77%	477 $0
Q1 2022 May 12, 2022	SELL	$0.81 - $1.51 $825 - $1,538	-1,019 Reduced 4.54%	21,426 $22,000
Q4 2021 Feb 10, 2022	SELL	$1.3 - $2.96 $8,314 - $18,932	-6,396 Reduced 22.18%	22,445 $29,000
Q3 2021 Nov 09, 2021	BUY	$2.35 - $3.93 $9,714 - $16,246	4,134 Added 16.73%	28,841 $76,000
Q2 2021 Aug 11, 2021	BUY	$3.49 - $11.34 $86,227 - $280,177	24,707 New	24,707 $101,000

Ticker PALI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,240,200
Market Cap $122M
Description
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzym...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.